Ellen Wang

Are you aged 50+ & had a spine fracture in the past 2yrs? You may be eligible for a study where you attend free education/training sessions 1x/week for 8 weeks. uwaterloo.ca/.../virtual-in…... Reviewed and received ethics clearance through Unity Health, McMaster University, and UBC.

Sjögren's syndrome is an inflammatory autoimmune disease where the body’s immune system attacks the body’s own organs, such as the tear and salivary glands, causing inflammation, dysfunction, dry eyes and dry mouth. On #worldsjogrensday, learn more: bit.ly/ACESjogrensEN

New BonES lab paper on Osteostrong and bone health, thanks for sharing @nick_krontiris ! link.springer.com/article/10.100…

📢Introducing PxP Africa! Led by @JoabWako and @breastlessAfrik PxP Africa will spotlight the critical role of patient partners—especially African patients—as active contributors in research, not just research participants. Learn more and register: pxphub.org/event/pxp-afri…

Newest publication in Physiotherapy Canada 📜 Please contact me if you would like a copy of the manuscript. @Arthritis_ARC @ACEJointHealth @CIHR_IMHA @LLi_1 @LKTphysio @PhysioKTBroker @SPORAlliance @clare_ardern @ArthritisSoc @JasminKMa #MSK #SelfManagement #SystematicReview

For Patients, By Patients. Register now for this free, virtual conference for anyone with an interest in health research. September 9th to September 12th 2025! pxphub.org/event/free-tic… @PxPHub @RonBeleno @DisabilitywAnna @TO_dpr @TrinityLowthian #PatientEngagement #PPI

🔄 1 day to go! World Sjögren’s Day is tomorrow — let’s get ready. ⏳ Set your reminder and share this post today. #SjögrenDay2025 #ShareYourVoice #Sjögrendisease #SjögrenAwareness #WorldSjögrenDay

🤖Artificial Intelligence is transforming arthritis care — from diagnosing & predicting flares to answering your questions. We want to hear YOUR voice! Take our #ACESurvey on #AI & arthritis care to shape its future in 🇨🇦 surveymonkey.com/r/ACESurveyonA… #Arthritis #PatientVoice

Approximately 6M people live with arthritis in Canada. We need to know what candidates & party leaders will do to ease our pain & improve our access to timely arthritis care if elected 🙌 bit.ly/4jbkNwX #cdnpoli #elxn2025 #elx45 #vote4arthritis @ArthritisSoc

All aspects of CASS have been co-created by a steering committee of patient partners and trainees including the event program, speakers and even the logo. ➡️Learn more and apply by April 28: bit.ly/CanadianArthri… @TO_dpr

This year's AHPA Pre-course featured @jwhittak_physio. In #CRArthritis 5, @ACEJointHealth's @KT_trainee interviews her about @soarknee, a virtual knee health program for those w/⬆️ risk of osteoarthritis from knee injury. Watch now: youtu.be/MecksJAmJMs #ASM25 @Arthritis_ARC

Power in patient partnerships. Do you have it? Do you share it? Don’t underestimate the power of power. Our preprint is live. doi.org/10.31219/osf.i… @JanelleBowden @PGee51 @alexhaagaard @anitarena @anetto @CodiePrimeau @ATricco @KT_trainee @LLi_1 @HettyMulhall

JointHealth™ express - #ArthritisAtHome – Risk factors for cardiovascular disease and arthritis & tools to predict risk. Watch now: arthritisathome.jointhealth.org/?p=6116 #HerHeartMatters #WearRedCanada @Arthritis_ARC @ArthritisSoc @SpArthritis @HeartandStroke @WCHospital @WomensHealthMag

Very timely paper 🗞️ would recommend a read for anyone who is in the patient/public engagement space! @ACEJointHealth @CherylKoehn @CodiePrimeau @LKTphysio @TrinityLowthian

📢 Weekend reading on power dynamics in #PatientEngagement in #Research. Preprint from our team that includes #PatientPartners and research allies and about 4 themes concerning power on #PPI teams - osf.io/preprints/osf/… .../1

*Everyone* involved in health research can learn something important from this awesome panel on Feb 5th. Speaker biographies are available here: pxphub.org/event/webinar-…

Welcome to Putting Patients First 2024! #PPF24 We're grateful to all who've joined us today, in-person or online. Excited for knowledge sharing and a rich discussion on learning communities. Join the livestream: bit.ly/40Ht05G. Follow this thread for highlights. 1/n

FDA has given FDA Breakthrough Therapy designation to Nipocalimab for treatment of adults w/ moderate-to-severe Sjögren’s disease. NIPO is an Ab to neonatal Fc receptor (FcRn), & was tested and shown effective in Sjog in the Phase 2 DAHLIAS study - a plenary presentation at…